Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis

DC. Dumut, M. Hajduch, AM. Zacharias, Q. Duan, I. Frydrych, Z. Rozankova, M. Popper, D. Garic, RA. Paun, A. Centorame, J. Shah, M. Mistrik, P. Dzubak, JB. De Sanctis, D. Radzioch

. 2025 ; 16 (-) : 1491450. [pub] 20250212

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009889

Advanced metastatic colorectal cancer (CRC) with deficient DNA mismatch repair (MMR-d), or immune-hot CRCs, show significantly improved clinical outcomes compared to MMR-proficient (MMR-p), or immune-cold CRCs. While the prior represents about 5% of all CRCs, the latter represent 95% and are characterized by low immunogenicity. This study investigates bis-diethyldithiocarbamate (CuET), a novel anticancer compound, and its impact on the colorectal cancer tumor microenvironment (TME). CuET is shown to convert immunologically inactive tumors into hotbeds of antitumor immune responses, marked by increased lymphocyte infiltration, heightened cytotoxicity of natural killer (NK) and T cells, and enhanced non-self recognition by lymphocytes. The potent anticancer cytotoxicity and in vivo safety and efficacy of CuET are established. In summary, CuET transforms the colorectal cancer TME, bolstering NK and T cell cytotoxicity and refining tumor cell recognition through non-classical activation via the NKG2D/NKG2DL axis. This study unveils a novel mechanism of action for CuET: a potent immunomodulator capable of turning cold tumors hot.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009889
003      
CZ-PrNML
005      
20250429135254.0
007      
ta
008      
250415e20250212sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2025.1491450 $2 doi
035    __
$a (PubMed)40013140
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Dumut, Daciana C $u Department of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada $u The Research Institute of the McGill University Health Centre, Infectious Diseases in Global Health Program, Montreal, QC, Canada
245    10
$a Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis / $c DC. Dumut, M. Hajduch, AM. Zacharias, Q. Duan, I. Frydrych, Z. Rozankova, M. Popper, D. Garic, RA. Paun, A. Centorame, J. Shah, M. Mistrik, P. Dzubak, JB. De Sanctis, D. Radzioch
520    9_
$a Advanced metastatic colorectal cancer (CRC) with deficient DNA mismatch repair (MMR-d), or immune-hot CRCs, show significantly improved clinical outcomes compared to MMR-proficient (MMR-p), or immune-cold CRCs. While the prior represents about 5% of all CRCs, the latter represent 95% and are characterized by low immunogenicity. This study investigates bis-diethyldithiocarbamate (CuET), a novel anticancer compound, and its impact on the colorectal cancer tumor microenvironment (TME). CuET is shown to convert immunologically inactive tumors into hotbeds of antitumor immune responses, marked by increased lymphocyte infiltration, heightened cytotoxicity of natural killer (NK) and T cells, and enhanced non-self recognition by lymphocytes. The potent anticancer cytotoxicity and in vivo safety and efficacy of CuET are established. In summary, CuET transforms the colorectal cancer TME, bolstering NK and T cell cytotoxicity and refining tumor cell recognition through non-classical activation via the NKG2D/NKG2DL axis. This study unveils a novel mechanism of action for CuET: a potent immunomodulator capable of turning cold tumors hot.
650    12
$a nádorové mikroprostředí $x účinky léků $x imunologie $7 D059016
650    12
$a lektinové receptory NK-buněk - podrodina K $x metabolismus $7 D055655
650    12
$a dithiokarb $x farmakologie $7 D004050
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    12
$a kolorektální nádory $x farmakoterapie $x imunologie $x metabolismus $x patologie $7 D015179
650    _2
$a myši $7 D051379
650    _2
$a měď $7 D003300
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buňky NK $x imunologie $x účinky léků $x metabolismus $7 D007694
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a ženské pohlaví $7 D005260
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hajduch, Marian $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Zacharias, Amanda M $u Department of Biomedical & Molecular Sciences, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada
700    1_
$a Duan, Qingling $u Department of Biomedical & Molecular Sciences, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada $u School of Computing, Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada
700    1_
$a Frydrych, Ivo $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia
700    1_
$a Rozankova, Zuzana $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Popper, Miroslav $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Garic, Dusan $u Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, United States
700    1_
$a Paun, Radu Alexandru $u The Research Institute of the McGill University Health Centre, Infectious Diseases in Global Health Program, Montreal, QC, Canada $u Department of Biomedical Engineering, McGill University, Montreal, QC, Canada
700    1_
$a Centorame, Amanda $u Department of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada $u The Research Institute of the McGill University Health Centre, Infectious Diseases in Global Health Program, Montreal, QC, Canada
700    1_
$a Shah, Juhi $u The Research Institute of the McGill University Health Centre, Infectious Diseases in Global Health Program, Montreal, QC, Canada
700    1_
$a Mistrik, Martin $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Dzubak, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a De Sanctis, Juan B $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
700    1_
$a Radzioch, Danuta $u Department of Experimental Medicine, Faculty of Medicine, McGill University, Montreal, QC, Canada $u The Research Institute of the McGill University Health Centre, Infectious Diseases in Global Health Program, Montreal, QC, Canada $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia $u Czech Advanced Technology and Research Institute, Palacky University Olomouc, Olomouc, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 16 (20250212), s. 1491450
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40013140 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135249 $b ABA008
999    __
$a ok $b bmc $g 2311337 $s 1246970
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 16 $c - $d 1491450 $e 20250212 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace